LAGUNA HILLS, Calif., Oct. 2, 2019 /PRNewswire/ – Sonendo®, Inc., developer of the GentleWave® System, announced today it had been named the winner of the 2019 OCTANe High Tech Awards for Outstanding Innovation in the Medical Technology category.
"We are honored to receive this award," said Bjarne Bergheim, President and Chief Executive Officer of Sonendo. "Developing products that improve patient outcomes is foundational to our core values and implicit within our brand promise to customers."
The GentleWave System redefines root canal therapy through Sonendo's innovative Multisonic Ultracleaning® technology. To learn more about the GentleWave Procedure, visit www.gentlewave.com.
The High Tech Awards (HTA) seeks to celebrate and recognize those individuals and companies who make Orange County a center of technology and medical technology innovation. In its 26th year, The High Tech Awards has recognized more than 95 innovative companies that are large and small, public and private.
Sonendo, Inc. is a privately-held company developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2,3 Sonendo is the parent company of TDO™ Software, the developer of the most widely used endodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05. 3Trope M et al. (1999) J Endod. 25:345–50.
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments, or events could differ materially from those disclosed in the forward-looking statements.